Wodack Karin H, Poppe Annika M, Tomkötter Lena, Bachmann Kai A, Strobel Cilly M, Bonk Sarah, Havel Jan, Heckel Kai, Gocht Andreas, Saugel Bernd, Mann Oliver, Izbicki Jakob R, Goetz Alwin E, Trepte Constantin J C, Reuter Daniel A
1Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 2Department of General, Visceral and Thoracic Surgery, Center of Surgical Sciences, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 3Laboratory of Pathology, Lübeck, Germany.
Crit Care Med. 2014 Dec;42(12):e741-51. doi: 10.1097/CCM.0000000000000657.
In severe acute pancreatitis, the administration of fluids in the presence of positive fluid responsiveness is associated with better outcome when compared to guiding therapy on central venous pressure. We compared the effects of such consequent maximization of stroke volume index with a regime using individual values of stroke volume index assessed prior to severe acute pancreatitis induction as therapeutic hemodynamic goals.
Prospective, randomized animal study.
University animal research laboratory.
Thirty domestic pigs.
After randomization, fluid resuscitation was started 2 hours after severe acute pancreatitis induction and continued for 6 hours according to the respective treatment algorithms. In the control group, fluid therapy was directed by maximizing stroke volume index, and in the study group, stroke volume index assessed prior to severe acute pancreatitis served as primary hemodynamic goal.
Within the first 6 hours of severe acute pancreatitis, the study group received a total of 1,935.8 ± 540.7 mL of fluids compared with 3,462.8 ± 828.2 mL in the control group (p < 0.001). Pancreatic tissue oxygenation did not differ significantly between both groups. Vascular endothelial function, measured by flow-mediated vasodilation before and 6 hours after severe acute pancreatitis induction, revealed less impairment in the study group after treatment interval (-90.76% [study group] vs -130.89% [control group]; p = 0.046). Further, lower levels of heparan sulfate (3.41 ± 5.6 pg/mL [study group] vs 43.67 ± 46.61 pg/mL [control group]; p = 0.032) and interleukin 6 (32.18 ± 8.81 pg/mL [study group] vs 77.76 ± 56.86 pg/mL [control group]; p = 0.021) were found in the study group compared with control group. Histopathological examination of the pancreatic head and corpus at day 7 revealed less edema for the study group compared with the control group (1.82 ± 0.87 [study group] vs 2.89 ± 0.33 [control group, pancreatic head]; p = 0.03; 2.2 ± 0.92 [study group] vs 2.91 ± 0.3 [control group, pancreatic corpus]; p = 0.025).
Individualized optimization of intravascular fluid status during the early course of severe acute pancreatitis, compared with a treatment strategy of maximizing stroke volume by fluid loading, leads to less vascular endothelial damage, pancreatic edema, and inflammatory response.
在重症急性胰腺炎中,与根据中心静脉压指导治疗相比,在存在液体反应性阳性的情况下给予液体与更好的预后相关。我们比较了将每搏量指数如此最大化的效果与使用重症急性胰腺炎诱导前评估的每搏量指数个体值作为治疗性血流动力学目标的方案的效果。
前瞻性、随机动物研究。
大学动物研究实验室。
30头家猪。
随机分组后,在重症急性胰腺炎诱导后2小时开始液体复苏,并根据各自的治疗算法持续6小时。在对照组中,通过最大化每搏量指数来指导液体治疗,而在研究组中,重症急性胰腺炎诱导前评估的每搏量指数作为主要血流动力学目标。
在重症急性胰腺炎的前6小时内,研究组共接受1935.8±540.7 mL液体,而对照组为3462.8±828.2 mL(p<0.001)。两组间胰腺组织氧合无显著差异。通过重症急性胰腺炎诱导前及诱导后6小时的血流介导性血管舒张测量的血管内皮功能显示,治疗间隔后研究组的损伤较小(-90.76%[研究组]对-130.89%[对照组];p=0.046)。此外,与对照组相比,研究组硫酸乙酰肝素水平较低(3.41±5.6 pg/mL[研究组]对43.67±46.61 pg/mL[对照组];p=0.032),白细胞介素6水平也较低(32.18±8.81 pg/mL[研究组]对77.76±56.86 pg/mL[对照组];p=0.021)。第7天对胰头和胰体的组织病理学检查显示,与对照组相比,研究组的水肿较轻(1.82±0.87[研究组]对2.89±0.33[对照组,胰头];p=0.03;2.2±0.92[研究组]对2.91±0.3[对照组,胰体];p=0.025)。
与通过液体负荷使每搏量最大化的治疗策略相比,在重症急性胰腺炎早期对血管内液体状态进行个体化优化可减少血管内皮损伤、胰腺水肿和炎症反应。